Study to investigate safety, tolerability and pharmacokinetics of AZD2423 in healthy volunteers - SAD

Exclusion Criteria

• - History of any clinically significant disease or disorder which, in the
• opinion of the investigator, may either put the subject at risk because of
• participation in the study,or influence the results or the subject's
• ability to participate in the study
• - History or presence of gastrointestinal, hepatic or renal disease or any
• other condition known to interfere with absorption, distribution,
• metabolism or excretion of drugs
• - Any clinically significant illness/infection or medical/surgical procedure
• or trauma,as judged by the Principal Investigator, within 3 months of the
• first administration of investigational product